Does TELOTRISTAT ETHYL Cause Disease progression? 148 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 148 reports of Disease progression have been filed in association with TELOTRISTAT ETHYL (Xermelo). This represents 2.6% of all adverse event reports for TELOTRISTAT ETHYL.
148
Reports of Disease progression with TELOTRISTAT ETHYL
2.6%
of all TELOTRISTAT ETHYL reports
29
Deaths
24
Hospitalizations
How Dangerous Is Disease progression From TELOTRISTAT ETHYL?
Of the 148 reports, 29 (19.6%) resulted in death, 24 (16.2%) required hospitalization.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TELOTRISTAT ETHYL. However, 148 reports have been filed with the FAERS database.
What Other Side Effects Does TELOTRISTAT ETHYL Cause?
Diarrhoea (798)
Nausea (610)
Constipation (592)
Abdominal pain (514)
Off label use (495)
Fatigue (395)
Flatulence (390)
Flushing (344)
Headache (320)
Drug ineffective (317)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which TELOTRISTAT ETHYL Alternatives Have Lower Disease progression Risk?
TELOTRISTAT ETHYL vs TEMAZEPAM
TELOTRISTAT ETHYL vs TEMODAR
TELOTRISTAT ETHYL vs TEMOZOLOMIDE
TELOTRISTAT ETHYL vs TEMSIROLIMUS
TELOTRISTAT ETHYL vs TENAMFETAMINE